<div id="readability-page-1"><p>Perpetual Ltd lessened its holdings in shares of  Ambev S.A. (NYSE:ABEV - Free Report) by 87.2% during the third quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The institutional investor  owned 168,569 shares of the company's stock after selling 1,146,522 shares during the period. Perpetual Ltd's holdings in Ambev were worth $376,000 at the end of the most recent quarter.</p><ul><li>5 Cheap Dividend Stocks: Which to Buy Now</li></ul><p>A number of other hedge funds and other institutional investors also recently made changes to their positions in ABEV. Invesco Ltd. grew its position in  Ambev by 98.6% during the first quarter. Invesco Ltd. now owns 3,803,683 shares of the company's stock worth $8,863,000 after buying an additional 1,887,987 shares in the last quarter.  American Century Companies Inc. lifted its position in shares of  Ambev by 10.0% during the 1st quarter. American Century Companies Inc. now owns 2,455,125 shares of the company's stock valued at $5,720,000 after acquiring an additional 222,768 shares during the period.  Raymond James Financial Inc. grew its holdings in shares of  Ambev by 9.3% during the 1st quarter. Raymond James Financial Inc. now owns 2,080,838 shares of the company's stock worth $4,848,000 after purchasing an additional 176,683 shares in the last quarter.  Northern Trust Corp increased its position in shares of  Ambev by 17.8% in the first quarter. Northern Trust Corp now owns 7,757,412 shares of the company's stock worth $18,075,000 after purchasing an additional 1,170,397 shares during the period.  Finally, Compound Planning Inc. increased its position in shares of  Ambev by 43.4% in the first quarter. Compound Planning Inc. now owns 116,930 shares of the company's stock worth $272,000 after purchasing an additional 35,383 shares during the period. 8.13% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Ambev Stock Up 0.4%</h2><p>ABEV stock opened at $2.49 on Monday. The firm has a 50-day moving average price of $2.42 and a 200-day moving average price of $2.34. Ambev S.A. has a 12 month low of $1.76 and a 12 month high of $2.63. The company has a current ratio of 1.15, a quick ratio of 0.86 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $39.24 billion, a P/E ratio of 13.83, a price-to-earnings-growth ratio of 2.71 and a beta of 0.70. </p><ul><li>14 best consumer staples dividend stocks</li></ul><p>Ambev (NYSE:ABEV - Get Free Report) last released its quarterly earnings data on Thursday, October 30th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.04. The business had revenue of $3.90 billion during the quarter, compared to analysts' expectations of $3.97 billion. Ambev had a net margin of 17.90% and a return on equity of 15.81%.  As a group, equities research analysts anticipate that  Ambev S.A. will post 0.18 EPS for the current fiscal year. </p><h2>Ambev Dividend Announcement</h2><p>The company also recently declared a special dividend, which will be paid on Friday, January 9th. Stockholders of record on Monday, December 22nd will be paid a $0.049 dividend. This represents a dividend yield of 1,351.0%. The ex-dividend date is Monday, December 22nd. Ambev's dividend payout ratio  is presently 27.78%. </p><h2>Analysts Set New Price Targets</h2><ul><li>3 Reasons Boston Beer Stock Could Finally Hop Higher</li></ul><p>A number of equities research analysts have issued reports on ABEV shares. Weiss Ratings  reiterated a &#34;hold (c)&#34; rating on shares of Ambev in a research note on Monday, December 15th. Sanford C. Bernstein  reaffirmed a &#34;market perform&#34; rating and set a $2.88 price target on shares of Ambev in a report on Wednesday, November 26th. Finally, Zacks Research raised shares of Ambev from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, September 30th. Nine equities research analysts have rated the stock with a Hold rating and one  has assigned  a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of &#34;Reduce&#34; and a consensus price target of $2.53.</p><p><b>Get Our Latest Report on ABEV</b></p><h2>Ambev Profile</h2> (Free Report)<p>Ambev <span>NYSE: ABEV<span></span></span> is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company's core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.  </p><p>The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.</p><h2>See Also</h2><ul><li>Five stocks we like better than Ambev</li><li>I Shouldn't Be Sending You This</li><li>Wall Street Stock picker Names #1 Stock of 2026</li><li>End of America update</li><li>They Laughed at $30. They Won’t Laugh at $70.</li><li>How Long Will $1M Last in Retirement?</li></ul><p><strong>Want to see what other hedge funds are holding ABEV?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFCRVY?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFCRVY"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Ambev Right Now?</h2><p>Before you consider Ambev, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.</p><p>While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ABEV

<p>Perpetual Ltd reduced its holdings in Ambev S.A. by 87.2% in Q3, selling 1,146,522 shares, now owning 168,569 shares worth $376,000. Other institutional investors adjusted their positions in Ambev, with notable increases by Invesco Ltd, American Century Companies Inc., and others. Ambev's stock opened at $2.49, with a market cap of $39.24 billion. Analysts have issued a Hold rating, with a consensus price target of $2.53.</p>

Perpetual Ltd Sells 1,146,522 Shares of Ambev S.A. $ABEV